![William D. Shrader](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William D. Shrader
Geen lopende functies
Profiel
William D.
Shrader worked as an Associate Director at Celera Group and as a Principal at Abbott Laboratories.
He also worked as a Senior Consultant at Edison Pharmaceuticals, Inc. from 2011 to 2014.
Shrader holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Illinois, which he received in 2011.
Eerdere bekende functies van William D. Shrader
Bedrijven | Functie | Einde |
---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Celera Group
![]() Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - |
Edison Pharmaceuticals, Inc.
![]() Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Hoofd Techniek/Wetenschap/O&O | 09-08-2011 |
Opleiding van William D. Shrader
University of California, Berkeley | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Edison Pharmaceuticals, Inc.
![]() Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Health Technology |
Celera Group
![]() Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |